YSBPW   $0.095  26.67% Market Closed

YS Biopharma Co Ltd
Total Cash 226.77M
totalCashPerShare 0.643
EBITDA
Total Debt 461.56M
quickRatio
currentRatio
Total Revenue
debtToEquity 70.159
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth 0.483
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -2.697
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon
trailingEps
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 24
lastUpdated July 16, 2023, 9:21 p.m.